West Pharmaceutical Services

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments.

CEO

Eric Mark Green

CEOEric Mark Green

Employees

10,800

Employees10,800

Headquarters

Exton, Pennsylvania

HeadquartersExton, Pennsylvania

Founded

1923

Founded1923

Employees

10,800

Employees10,800

WST Key Statistics

Market cap

16.96B

Market cap16.96B

Price-Earnings ratio

34.03

Price-Earnings ratio34.03

Dividend yield

0.37%

Dividend yield0.37%

Average volume

871.24K

Average volume871.24K

High today

$237.20

High today$237.20

Low today

$231.43

Low today$231.43

Open price

$235.59

Open price$235.59

Volume

757.95K

Volume757.95K

52 Week high

$322.34

52 Week high$322.34

52 Week low

$187.43

52 Week low$187.43

Stock Snapshot

The current West Pharmaceutical Services(WST) stock price is $235.46, with a market capitalization of 16.96B. The stock trades at a price-to-earnings (P/E) ratio of 34.03 and offers a dividend yield of 37.2%.

During the trading session on 2026-03-13, West Pharmaceutical Services(WST) shares reached a daily high of $237.20 and a low of $231.43. At a current price of $235.46, the stock is +1.7% higher than the low and still -0.7% under the high.

Trading volume for West Pharmaceutical Services(WST) stock has reached 757.95K, versus its average volume of 871.24K.

The stock's 52-week range extends from a low of $187.43 to a high of $322.34.

WST News

Nasdaq 1d

West Pharmaceutical Services Now #396 Largest Company, Surpassing Viatris

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, West Pharmaceutical Services, Inc. (Symbol: WST) has ta...

Simply Wall St 4d

Assessing West Pharmaceutical Services Valuation After Earnings Beat And Upbeat 2026 GLP 1 Guidance

West Pharmaceutical Services (WST) is back in focus after fourth quarter 2025 results beat expectations and management issued upbeat 2026 guidance, highlighting...

Nasdaq 4d

West Pharmaceutical Services President And CEO Eric Green To Retire

(RTTNews) - West Pharmaceutical Services, Inc. (WST) announced that Eric Green plans to retire from his positions as President, Chief Executive Officer and Chai...

Analyst ratings

79%

of 19 ratings

Buy

78.9%

Hold

21.1%

Sell

More WST News

TipRanks 4d

West Pharmaceutical says CEO Eric Green to retire

West Pharmaceutical (WST) Services announced that Eric Green has informed the Board of Directors that he plans to retire from his positions as President, CEO an...

Simply Wall St 6d

How Investors May Respond To West Pharmaceutical Services Earnings Beat, Higher Dividend, Buybacks And GLP-1 Outlook

In the past quarter, West Pharmaceutical Services reported adjusted earnings per share of US$2.04 on revenue of US$805.00 million, raised its dividend, and auth...

Simply Wall St 7d

Is West Pharmaceutical Services Pricing Look Justified After Mixed Multi Year Share Performance

If you are wondering whether West Pharmaceutical Services is priced attractively right now, the key question is how its current share price stacks up against di...

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.